HORIZON
Project-COMFORT
Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
- Programme
- Horizon Europe
- Started
- Ends
- Duration
- 42 months
- Total cost
- EUR 6,675,735
- EU contribution
- EUR 3,038,705
- Participants
- 24 from 10 countries
- Topic
- HORIZON_HORIZON-JU-IHI-2023-04-02-two-stage
- Grant agreement
- 101163781
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Bayer Aktiengesellschaft | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Jones Lang Lasalle Se | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Lilly Deutschland GmbH | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Miebach Consulting GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Siemens Healthineers AG | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Institut Servier D'Innovation Therapeutique | FRFrance | Associated partner | Not stated | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Labcorp Early Development Laboratories Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Medipace Limited | GBUnited Kingdom | Associated partner | EUR 0 | PIC (1.00) |
| Collaborate Healthcare- Kainotomes Ypiresies Ygeias Ike | GRGreece | Participant | EUR 155,949 | PIC (1.00) |
| Bayer SpA | ITItaly | Associated partner | EUR 0 | PIC (1.00) |
| Pharma Quality Europe SRL | ITItaly | Participant | EUR 168,290 | PIC (1.00) |
| Stichting Sanquin Bloedvoorziening | NLNetherlands | Participant | EUR 64,648 | known name (0.95) |
| Stichting Vu | NLNetherlands | Participant | EUR 177,580 | known name (0.95) |
| Astrazeneca AB | SESweden | Participant | EUR 0 | PIC (1.00) |
| Capitainer AB | SESweden | Participant | EUR 32,740 | PIC (1.00) |
| International Doping Tests Management AB Idtm | SESweden | Participant | EUR 16,240 | PIC (1.00) |
| Eli Lilly and Company | UMU.S. Outlying Islands | Participant | EUR 0 | PIC (1.00) |
| Abbvie Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Pfizer Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Rhinostics, Inc. | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| Tasso Inc | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| YourBio Health, Inc. | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 24 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.